Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

NCT00045968 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

348

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme
Glioblastoma
GBM
Grade IV Astrocytoma
Glioma
Brain Cancer
Brain Tumor

Interventions

DRUG: Dendritic cell immunotherapy

Sponsor

Northwest Biotherapeutics